BridgeBio Pharma, Inc. Common Stock (BBIO) Financials
Key financial figures for BridgeBio Pharma, Inc. Common Stock (Q2 2026).
- Revenue
- $244M
- Net Income
- -$156M
- EPS
- $-0.78
- Total Assets
- $1.2B
- Operating Cash Flow
- -$71M
Full income statement, balance sheet, and cash flow for BridgeBio Pharma, Inc. Common Stock on SentiSense.